Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Observational Study
100%
Gut
72%
Reassurance
72%
Clinical Prediction Model
60%
Biological Marker
53%
Antibiotics
53%
Antipyretic
42%
Logistic Regression Analysis
24%
Acute Hepatitis
21%
Protocol Compliance
21%
Adeno Associated Virus 2
21%
Pathogen
21%
Emergency Care
21%
Antiinfective Agent
21%
Enzyme Linked Immunosorbent Assay
21%
Bacterial Pneumonia
21%
Radioimmunoassay
21%
Help Seeking Behavior
21%
Patient Referral
21%
Procalcitonin
21%
Antibiotic Therapy
17%
Partial Least Squares Regression
17%
Clinical Decision Making
14%
Feature Extraction
12%
Sepsis
11%
Human Herpesvirus 6
10%
Bootstrapping
10%
Physical Disease by Body Function
10%
Clinical Feature
8%
Liquid Chromatography-Mass Spectrometry
8%
Socioeconomic Status
7%
Effect Size
7%
Acquired Immune Deficiency Syndrome
7%
Human Immunodeficiency Virus
7%
Immune Deficiency
7%
Penicillin
6%
Akaike Information Criterion
5%
Tachypnea
5%
Lumbar Puncture
5%
Breathing
5%
Bronchiolitis
5%
Escherichia coli
5%
Streptococcus Group A
5%
Influenza B
5%
Influenza A
5%
Virus Detection
5%
Epstein Barr Virus
5%
Enterovirus
5%
Peripheral Circulation
5%
Respiratory Syncytial Virus
5%
Pharmacology, Toxicology and Pharmaceutical Science
Observational Study
89%
Biological Marker
64%
Antibiotics
61%
Antiinfective Agent
48%
Clinical Feature
42%
Antipyretic Agent
42%
Respiratory Virus
32%
Infectious Agent
30%
Hematogenous Osteomyelitis
21%
Osteomyelitis
21%
Enzyme-Linked Immunosorbent Assay
21%
Bacterial Pneumonia
21%
Akaike Information Criterion
21%
Physical Disease by Body Function
21%
Procalcitonin
21%
Streptococcus pyogenes
21%
C Reactive Protein
21%
Syndrome
14%
Bronchiolitis
10%
Childhood Mortality
10%
Human Respiratory Syncytial Virus
10%
Sepsis
10%
Prevalence
9%
Penicillin
9%
Oxacillin
7%
Clindamycin
7%
HIV
7%
Infectious Complication
7%
Acquired Immune Deficiency Syndrome
7%
Immune Deficiency
7%
Influenza Virus
6%
Escherichia coli
5%
Streptococcus Group A
5%
Enterovirus
5%
Influenza B
5%
Influenza A
5%
Immunology and Microbiology
Infectious Agent
49%
Glycopeptide
21%
Glycosylation
21%
Staphylococcus Aureus
21%
Prevalence
21%
Adeno Associated Virus 2
21%
Penicillin
21%
COVID-19
21%
Virulence Factor
21%
Limb
21%
Procalcitonin
21%
Respiratory Virus
21%
Leukocyte Count
21%
Blood Plasma
17%
C-Reactive Protein
17%
Human Respiratory Syncytial Virus
10%
Human Herpesvirus 6
10%
Protein Processing
7%
Protein Expression
7%
Influenza Virus
6%
Neutrophil Count
6%